| Line item | 2025-10-31 FY | 2024-10-31 FY | 2023-10-31 FY | 2022-10-31 FY | 2021-10-31 FY |
|---|---|---|---|---|---|
| Revenue | $5.38B | $4.98B | $5.46B | $5.42B | $4.94B |
| Cost of Revenue | $2.04B | $1.85B | $1.93B | $1.97B | $1.87B |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – |
| R&D | $1.01B | $919.00M | $882.00M | $841.00M | $811.00M |
| SG&A | $1.47B | $1.40B | $1.31B | $1.28B | $1.20B |
| Operating Income | $876.00M | $833.00M | $1.36B | $1.33B | $1.08B |
| Interest Expense | $96.00M | $84.00M | $78.00M | $79.00M | $79.00M |
| Tax Expense | $213.00M | $251.00M | $300.00M | $161.00M | $116.00M |
| Net Income | $850.00M | $614.00M | $1.06B | $1.12B | $894.00M |
| EPS (basic) | 4.9300 | 3.5300 | 5.9500 | 6.2300 | 4.8400 |
| EPS (diluted) | 4.9100 | 3.5100 | 5.9100 | 6.1800 | 4.7800 |
| Shares (diluted) | $173.00M | $175.00M | $179.00M | $182.00M | $187.00M |